3 studies today on antibodies & Omicron.
🔵 There may be a large drop in neutralization of Omicron
🔵 Antibodies stop Omicron well in hybrid immunity (infected+vax)
🔵 Sotrovimab is active versus Omicron

Take home: Get vaccinated. Get boosted. Immune system is clever. 🧵 1/n
Live virus neutralization preliminary data from @Sigallab in South Africa found a 41x drop in vax neutralization of Omicron. That is a large drop. Seeing hybrid immunity do much better is encouraging. Average Omicron neutralization of ~1,000 was good (>vax neut of WT). 2/n
Neutralizing breadth in hybrid immunity is outstanding. And we know that 3-dose (boosted) vaccine partially recapitulates that improvement in breadth. 3/n
The hope is that, based on neutralizing data of other variants, 3-dose vaccinated neutralization of Omicron may be reasonable—MAY. *speculation* for now. 4/n
A helpful reference point is a difficult previous SARS-CoV-2 variant: Beta.
Booster immunization studies by Moderna and Pfizer showed that, while there was a 15x drop in neutralization of Beta for people vaxxed with 2-dose, Abs vs Beta were MUCH better after a booster shot. ~15x
(regular booster. not even Beta). ~15x improvement. Such that 3-dose RNA neutralization of Beta was as strong as 2-dose neutralization of 'regular' SARS2. 6/n
That's because the immune system B cells can frequently learn how to recognize a virus better and better, and make guesses about potential variants. 7/n
It is outstanding that @sigallab got these data so quickly. What many of us want to see is:
* Head-to-head comparisons against other variants, because of the broader experience with them.
* Neutralization of Omicron by serum from people with 3-doses of an RNA vaccine. 8/n
A second study also posted today, with Omicron pseudovirus neutralization data, from the Karolinska. This study had four notable findings:
a) 40x drop in Omicron neutralization by the WHO standard plasma, from COVID donors.
b) 5x drop in Omicron neutralization by people with hybrid immunity
c) 7x drop in Omicron neutralization by random blood donors. Presumably mostly vaxxed and uninfected? Unknown
d) Minimal difference in neutralization of Omicron versus Delta
Those last three observations (b, c, d) are pretty close to the best case scenario I was considering. 14/n
They must have gotten these data in about a week, which is very impressive! 15/n
Like everything in science, it is really valuable to get data from multiple labs, for confirmation and because not everyone does experiments exactly the same way. So it will be very valuable to see other studies in the coming days. 16/n
I do expect there to be T cell data related to Omicron in the next week or so. 17/n
Regarding memory B cells: The hybrid immunity outcomes and the 3-dose (boosted) RNA vaccine outcomes combined with the Sigal and Murrell data indicate that memory B cells have a good chance of recognizing Omicron well.(see above) But I would like to see more direct data. 18/n
Monoclonal Sotrovimab retains activity against Omicron
Good news!
A 2.7x shift, so it should still be an effective COVID therapeutic drug in high risk patients. 18/n
biorxiv.org/content/10.110…
So, again, current take home messages for Omicron immunity: Get vaccinated. Get boosted. Hybrid immunity is good.
end/n
Main figure of the Sheward / Murrell preprint. (I forgot it above)

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Prof. Shane Crotty

Prof. Shane Crotty Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @profshanecrotty

2 Nov
This week’s Crotty lab Journal Club, quite a surprising paper:
"Early developing B cells undergo negative selection by central nervous system-specific antigens in the meninges” 
Selected by postdoc Zeli Zhang 🧵
@ImmunityCP
sciencedirect.com/science/articl…
The authors identified early B cell development in the meningeal of mice and non-human primates, which was quite surprising. Image
Meningeal developing B cells were replenished from hematopoietic stem cell (HSC)-derived progenitors. Image
Read 6 tweets
29 Oct
What COVID vaccine would I give my kid?
If I had a kid age 5-11, I would get them the Pfizer vaccine, ASAP.
Even if the Moderna vax were available, I would go with the Pfizer vax for my kids. Because the Pfizer vaccine is a 10mcg dose. 🧵
10mcg Pfizer gave great immune responses in 5-11 year olds in the Phase 2/3 clinical trial, as good as 30mcg in 20 year olds ( equal antibody levels & ~100% antibody positive). Great to see the kids COVID-19 vaccine results from Pfizer provided to the FDA.
Given that kids generally have a much milder course of COVID-19 disease, having a level of immunity equal to that of young adults (or somewhat less than young adults that got the Moderna vaccine) should be more than enough for a 5-11 year old.
Read 14 tweets
25 Oct
What should I get as the 2nd dose? That's a question I get a lot.

If it were me, and I had only gotten 1-dose of vaccine & was soon to get my 2nd dose, here's what I would do:
1st dose + 2nd dose
J&J + Mod
Pfizer + Mod
Mod + Mod
See a pattern? 🙂 Moderna 2nd gives the most robust immune response with any of the others. But Pfizer is pretty close! (and I'd get 100mcg Moderna if I could)
Both in the Atmar/Lyke et al. work, and multiple published studies of AZ vax + RNA 2nd, getting RNA vaccine as the 2nd dose after an adeno vector has resulted in better antibody and T cell responses, compared to 2 doses of adeno.
Read 6 tweets
25 Oct
1-dose J&J is ok for a while, but needs a 2nd dose of vaccine (any) by 6 months. Anytime after 2 months is fine. A short thread on the recent J&J data to the FDA . 🧵
fda.gov/advisory-commi…
J&J 1-dose clinical trial efficacy.
These data, from a placebo controlled clinical trial for efficacy + safety, are robust. They are also consistent w/ multiple "real world" studies. Efficacy v. cases, hospitalizations, and deaths isn't as good as mRNA vaccines, across 6 months.
Or graphically:
Read 8 tweets
25 Oct
Is it good to mix COVID vaccines?

This is a really great clinical study by Lyke et al., reported at the recent FDA meeting.

Mix-and-match COVID vaccines

fda.gov/advisory-commi…
Mix-and-match COVID vaccines
Key findings:
🔵   mRNA + mRNA combinations are similar
🔵   J&J + mRNA gives much higher antibodies than J&J + J&J
🔵   No T cell data (sigh)
All the key data:
Read 11 tweets
19 Oct
Why isn't there a Delta variant vaccine?

I hear this a lot. 🧵 Three reasons:
1. The regular vaccines give great booster responses against Delta and other variants.
2. “Original recipe’ vaccine is better suited for other variants
3. It is faster to proceed with original vaccines
1/ The regular vaccines give great booster responses against Delta and other variants
This was first shown by Moderna, with 'original recipe' vaccine booster, compare to Beta booster.
nature.com/articles/s4159…
And for T cells, the T cell epitopes between variants are highly conserved, so the 'original recipe' vaccine should be a good booster. Though no T cell booster data are published.
doi.org/10.1016/j.xcrm…
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(